Fluoxetine plus lithium for treatment of mental health impairment in Long Covid
Abstract Purposes (1) To summarize the mental conditions that may accompany persistent symptoms following acute infection by SARS-CoV-2, often termed Long Covid; (2) to formulate treatment based upon the brain cells that are dominantly affected. Methods (1) Review the reports relating to the mental...
Main Author: | Jeffrey Fessel |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2023-01-01
|
Series: | Discover Mental Health |
Subjects: | |
Online Access: | https://doi.org/10.1007/s44192-022-00027-w |
Similar Items
-
Fluoxetine Can Inhibit SARS-CoV-2 In Vitro
by: Arthur Dechaumes, et al.
Published: (2021-02-01) -
Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19
by: Mohamed Mahdi, et al.
Published: (2022-03-01) -
Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model
by: David Péricat, et al.
Published: (2022-11-01) -
Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine
by: Sebastian Schloer, et al.
Published: (2020-01-01) -
Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro
by: Linda Brunotte, et al.
Published: (2021-09-01)